ADIPOQ and fatty liver disease: Despite the expected positive effects observed in the PPARγ S273 phosphorylation blockage, such as an increase in insulin sensitivity, adiponectin levels, and a decrease in plasma insulin in the fed state, our KI animals presented some negative effects, such as increased eWAT, liver steatosis, and decreased hepatic triglyceride storage.